Global Leading Market Research Publisher QYResearch announces the release of its latest report “Packaging for Solid Dosage Forms – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Packaging for Solid Dosage Forms market, including market size, share, demand, industry development status, and forecasts for the next few years.
Market Analysis: A Steady Growth Trajectory in Pharmaceutical Primary Packaging
The global packaging for solid dosage forms market is positioned for sustained growth over the forecast period, driven by the expanding global pharmaceutical market, increasing demand for tablets and capsules, and the critical need for packaging solutions that ensure product stability, safety, and user convenience while meeting stringent regulatory requirements. According to QYResearch’s latest market intelligence, the market was valued at US$ 26,030 million in 2025 and is projected to reach US$ 35,950 million by 2032, reflecting a compound annual growth rate (CAGR) of 4.8%. In volume terms, estimated sales reached approximately 9.12 million tons in 2024, with an average global price of approximately US$ 2,732 per ton.
For pharmaceutical manufacturers, packaging engineers, and quality assurance professionals, the core challenge in solid dosage form packaging has intensified: protecting tablets, capsules, and granules from moisture, light, and mechanical damage throughout storage and transportation while ensuring patient safety through child-resistant features and providing user-friendly access. Packaging for solid dosage forms addresses this critical need by providing the protective materials and containers used primarily for tablets, capsules, and granules, designed to ensure product stability, safety, and user convenience. Common packaging types include blister packs, bottles, and sachets or pouches, with materials and sealing methods selected based on the characteristics of the medicine. Components such as child-resistant caps, moisture-resistant caps, or foil liners can also be incorporated to protect the product from environmental factors during storage and transportation.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6096699/packaging-for-solid-dosage-forms
Key Industry Characteristics Shaping Market Dynamics
1. Diverse Packaging Formats for Solid Dosage Forms
The packaging for solid dosage forms market encompasses three primary packaging formats:
Blister Packs: Dominant segment for unit-dose packaging, offering individual cavity protection, moisture barrier, and tamper evidence. Widely used for tablets and capsules requiring precise dosing and extended shelf life.
Bottles: High-volume packaging for solid dosage forms, available in plastic (HDPE, PET, PP) or glass. Used for prescription and over-the-counter medications requiring bulk dispensing.
Sachets and Pouches: Flexible packaging for single-dose or multi-dose applications, commonly used for granules, powders, and effervescent tablets.
Others: Specialty packaging including unit-dose cups, tubes, and custom configurations.
2. Critical Protection Features
The packaging for solid dosage forms market demands specialized protective features:
Moisture resistance: Foil liners, desiccants, and moisture-barrier materials prevent degradation of moisture-sensitive formulations
Child-resistant (CR) features: CR caps and blister packaging meeting regulatory requirements for pediatric safety
Light protection: Opaque materials, foil liners, and colored bottles protecting light-sensitive drugs
Tamper evidence: Seals, shrink bands, and blister backing providing visible evidence of tampering
Dispensability: User-friendly opening features for patient adherence
3. Application Segmentation Across Solid Dosage Forms
The packaging for solid dosage forms market serves diverse solid dosage applications:
Capsules: Largest segment, encompassing hard and soft gelatin capsules requiring moisture protection and individual cavity blister packaging
Tablets: Immediate-release, extended-release, and specialty tablets requiring appropriate barrier protection
Others: Granules, powders, and lozenges
4. Competitive Landscape and Market Concentration
The packaging for solid dosage forms market features a fragmented but established competitive landscape:
Global Flexible Packaging Leaders:
Amcor, Constantia Flexibles: Global leaders in flexible and blister packaging
ACG Pharmapack: Integrated pharmaceutical packaging solutions
Bilcare, Liveo Research: Specialized pharmaceutical packaging
Rigid Packaging Leaders:
Gerresheimer, Stevanato Group: Glass and plastic packaging for pharmaceuticals
West Pharmaceutical Services: Elastomeric components and packaging systems
AptarGroup, Weener Plastics Group: Dispensing and closure systems
Specialty Materials Providers:
Mitsubishi Chemical, Sumitomo Bakelite, Klöckner Pentaplast: Rigid films and barrier materials
Origin Pharma Packaging, Shriji Polymers, Pravesha: Regional pharmaceutical packaging specialists
Asia-Pacific Leaders:
Bormioli Pharma, Jiangsu Zhongjin Matai: Glass and plastic packaging
Sichuan Hui Li Industry, Harbin Pengcheng New Materials, Shandong Ujoin Medical Technology: China-based manufacturers
Sunkey Packaging, Hubei Hongyu New Packaging Materials, Baoli Packaging: Regional suppliers
Exclusive Industry Perspective: Blister Packaging vs. Bottle Packaging
A critical distinction within the packaging for solid dosage forms market lies between blister packaging and bottle packaging:
Blister Packaging: Characterized by:
Unit-dose precision: Individual cavity protection for each dose
Superior barrier: Excellent moisture and oxygen barrier with aluminum-based structures
Child-resistant options: CR blister packaging meeting regulatory standards
Tamper evidence: Clear indication of package integrity
Higher cost: Premium per-dose cost compared to bottles
Applications: Moisture-sensitive drugs, prescription medications, unit-dose compliance
Bottle Packaging: Characterized by:
Bulk dispensing: Multiple doses in a single container
Cost-effective: Lower per-dose cost for high-volume medications
Recloseability: Cap closure for repeated access
Child-resistant caps: CR closures meeting safety standards
Moisture protection: Desiccant canisters and moisture-barrier liners
Applications: High-volume prescriptions, OTC medications, stable formulations
This divergence influences material selection, with blister packaging dominating for moisture-sensitive and high-value drugs requiring extended shelf life, while bottle packaging serves stable, high-volume formulations with cost-sensitive profiles.
Recent Industry Developments and Market Implications
Recent developments have reinforced the market’s growth trajectory:
Pharmaceutical market growth: Expanding global pharmaceutical manufacturing driving demand for primary packaging
Child-resistant packaging: Regulatory requirements for pediatric safety driving CR feature adoption
Patient adherence: Blister packaging for compliance packaging and unit-dose dispensing
Sustainability focus: Development of recyclable blister packaging and reduced-plastic bottle solutions
Asia-Pacific growth: Expanding pharmaceutical manufacturing in China, India, and Southeast Asia
Market Challenges and Strategic Considerations
Despite steady growth, the packaging for solid dosage forms market faces significant challenges:
Material costs: Raw material price volatility impacting packaging costs
Regulatory complexity: Evolving packaging regulations across regions
Sustainability demands: Pressure for recyclable, reduced-waste packaging solutions
Competition from alternatives: Emerging packaging technologies and formats
Child-resistant compliance: Ensuring CR features meet evolving regulatory standards
Strategic Implications for Industry Decision-Makers
For pharmaceutical packaging executives, drug developers, and investors, the packaging for solid dosage forms market presents clear strategic considerations:
Format selection: Match packaging format (blister, bottle, sachet) to drug characteristics, patient population, and market requirements
Barrier performance: Align moisture and oxygen protection with drug stability requirements
Child-resistant features: Ensure CR packaging meets regulatory standards for target markets
Sustainability: Invest in recyclable and reduced-carbon packaging solutions
Global expansion: Support pharmaceutical manufacturing growth in emerging markets
Conclusion
As the global pharmaceutical market expands and the demand for safe, stable, user-friendly packaging grows, packaging for solid dosage forms remains essential for protecting tablets, capsules, and granules from environmental factors while ensuring patient safety and convenience. With a projected market value of US$ 35.95 billion by 2032 and a 4.8% CAGR, the industry offers steady growth opportunities for established pharmaceutical packaging leaders and specialized packaging suppliers. The strategic imperative is clear: deliver protective, compliant packaging; support patient safety through child-resistant features; and enable efficient, high-quality pharmaceutical manufacturing.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
